Kinase Inhibition in Multiple Myeloma: Current Scenario and Clinical Perspectives
Sign Up to like & getrecommendations! Published in 2022 at "Pharmaceutics"
DOI: 10.3390/pharmaceutics14091784
Abstract: Multiple myeloma (MM) is a blood cell neoplasm characterized by excessive production of malignant monoclonal plasma cells (activated B lymphocytes) by the bone marrow, which end up synthesizing antibodies or antibody fragments, called M proteins,… read more here.
Keywords: inhibition multiple; myeloma; current scenario; kinase inhibition ... See more keywords